Manufacturer record

Horizon Bioceuticals Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Horizon Bioceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between October 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: CE-25022, Rabeprazole Sodium (EC) & Domperidone (SR) Capsules (exp Apr 2027). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to declared formula, in respect of content of Rabeprazole sodium. Listed in the September 2026 alert.

Records by type

2 records linked to Horizon Bioceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Oct 2025 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
2
Products affected
Assay
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2025 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Rabeprazole Sodium (EC) & Domperidone (SR) Capsules Batch CE-25022Mfg May 2025 · Exp Apr 2027 The sample does not conform to declared formula, in respect of content of Rabeprazole sodiumOther LUCKNOW, Uttar PradeshState lab Sep 2026
Levocetirizine Dihydrochloride & Montelukast Sodium Orally Disintegrating Tablets (MONSTAR-LC KID) Batch TL-23109Mfg Dec 2023 · Exp Nov 2025 Average weight and Assay (for Levocetirizine Dihydrochloride)Assay DTL, PuducherryState lab Oct 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.